Diasorin | DIA - Ebitda

Stock Price
59.82
Daily Change
0.02 0.03%
Monthly
1.39%
Yearly
-39.40%
Q2 Forecast
58.25

Diasorin reported EUR92M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Amplifon EUR 107.33M 38.85M Sep/2025
Avanos Medical USD 10M 73.9M Sep/2025
Brookdale Senior Living USD 105.56M 5.51M Dec/2025
Cencora USD 1.2B 42.41M Dec/2025
Diasorin EUR 92M 5M Dec/2025
Encompass Health USD 335.6M 35.5M Dec/2025
Enovis USD 111.9M 17.1M Dec/2025
GE HealthCare Technologies USD 1.1B 187M Dec/2025
OPKO Health USD 75.53M 144.7M Sep/2025
Pediatrix Medical Group USD 65.84M 21.47M Dec/2025
Veradigm USD 38.81M 29.61M Sep/2022
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025